Correction to: New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024
Abstract
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsEicosanoids and Hypertension Pharmacology
This is a correction to: Juan Tamargo, Stefan Agewall, Giuseppe Ambrosio, Claudio Borghi, Elisabetta Cerbai, Gheorghe A Dan, Heinz Drexel, Péter Ferdinandy, Erik Lerkevang Grove, Roland Klingenberg, Joao Morais, William Parker, Bianca Rocca, Patrick Sulzgruber, Anne Grete Semb, Samuel Sossalla, Juan Carlos Kaski, Dobromir Dobrev, New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024, European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 3, May 2025, Pages 292–317, https://doi.org/10.1093/ehjcvp/pvaf012
In the originally published version of the manuscript, there were errors in two affiliations. Affiliation ^7^ should read: “Carol Davila. University of Medicine, Academy of Romanian Scientist, Bucharest, Sector 2, Romania” instead of: “Carol Davila. University of Medicine, Bucharest, Sector 2, Romania”. Affiliation ^8^ should read: “Vorarlberg Institute for Vascular Investigation & Treatment (VIVIT), 6800 Feldkirch, Austria” instead of: “Academy of Romanian Scientist, Vorarlberg Institute for Vascular Investigation & Treatment (VIVIT), 6800 Feldkirch, Austria”.
These emendations hve been made to the article.